Skip to content
Intellectual Property News.com logo
Mandour & Associates, APC logo

Menu

Intellectual Property News.com

HomeTrademark NewsCopyright NewsPatent News

GlaxoSmithKline

Subscribe to GlaxoSmithKline

Union Sues Glaxo, Teva Over Lamictal Pay-For-Delay Patent Deal

By Mandour & Associates on October 26, 2012
Posted in IP Litigation News, Patent News

pills-tablets.jpgIPNews® – GlaxoSmithKline LLC and Teva Pharmaceutical Industries Ltd. were accused in a new class action in New Jersey federal court on Thursday of striking illegal deals to delay the entry of generic versions of Glaxo’s epilepsy drug Lamictal to the market until Glaxo’s patent for it expired.

Glaxo sued Teva after it filed an…

Stay Connected

RSS Twitter Facebook LinkedIn

Recent Updates

  • NBC Is Going After the ‘Dunder Mifflin’ Trademark… Again
  • Eminem Takes on Two ‘Real Housewives’ Over Slim Shady Trademark
  • “100% That Bitch” Lizzo Trademark Trounces USPTO Precedent
  • Jack Daniels Takes on Dog Toy Trademark
  • Trump Wanted to Trademark “Rigged Election.” Why It Didn’t Work

IP Blogs

  • PatentlyO
  • The Trademark Blog
  • Duets Blog
  • Likelihood of Confusion
  • The TTABlog
  • IPWatchDog

IP Links

  • uspto.gov
  • copyright.gov
  • google patents
  • wipo.int
  • iptla.org

Archives

HomeAboutServicesContactDisclaimerPrivacy Policy

IntellectualPropertyNews™

Mandour & Associates, APC logo
Los Angeles|Orange County|San Diego
RSS Twitter Facebook LinkedIn

About Our Firm

Mandour & Associates, APC is a southern California law firm with a singular focus: to assist businesses with issues related to intellectual property law.

Read More...
Copyright © 2023, Mandour & Associates, APC. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo